Medicare To Use Evidence Development For Off-Label Drug Use? CMS Guidance Unclear

Manufacturers may want to seek CMS' advice on how Medicare's "coverage with evidence development" applies to drugs, despite – or perhaps as a result of – a new final CED guidance.

Under CED, manufacturers agree to conduct clinical studies as a condition for obtaining coverage of their product. It can be part of a National Coverage Determination, under which a CMS...